RHON-KLINIKUM AG (GB:0NQH)
LSE:0NQH
0NQH Stock Chart & Stats
€13.20
€0.00(0.00%)
At close: 4:00 PM EST
€13.20
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€11.40 - €16.40
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00
Market Cap
€836.73M
Enterprise Value€788.65M
Total Cash (Recent Filing)€346.19M
Total Debt (Recent Filing)€146.87M
Price to Earnings (P/E)20.4
Beta-0.21
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding66,962,470
10 Day Avg. Volume1
30 Day Avg. Volume2
Financial Highlights & Ratios
PEG Ratio-1.23
Price to Book (P/B)0.64
Price to Sales (P/S)0.44
P/FCF Ratio-24.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.76
Revenue Forecast (FY)€1.79B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetThe company’s low leverage and rising equity provide a durable financial cushion that supports operating flexibility and downturn resilience. With total debt reduced and sizable equity, RHÖN-KLINIKUM can absorb temporary cash-flow variability, invest selectively, and access capital without immediate solvency pressure.
Multi-year Revenue RecoveriesRecurring double-digit revenue recoveries in 2023 and 2025 indicate structural patient demand and pricing/reimbursement realization across hospital services. These rebounds suggest the business can regain volume and revenue momentum after setbacks, supporting medium-term topline stability if operational issues are addressed.
Proven Cash-generation CapacityPrior years’ strong operating cash flow shows the underlying hospital network can generate meaningful cash from operations. This historical cash generation demonstrates capacity to self-fund investments and weather cyclical pressures if 2025’s weakness proves temporary and cost conversion recovers.
Bears Say
Sharp EBIT Collapse In 2025A near-total collapse in operating profit signals structural margin pressure or major one-off costs that materially reduce operating leverage. Persistently depressed EBIT undermines reinvestment, raises sensitivity to reimbursement changes, and could force cost restructuring or limit strategic initiatives over the medium term.
Negative Free Cash Flow In 2025A shift to negative free cash flow erodes liquidity and increases reliance on external funding despite low net debt. If negative FCF persists, the company may need to curtail capex, seek financing, or use reserves, reducing strategic optionality and raising refinancing or cost-of-capital risk over the coming quarters.
Thin Margins And Low ROESubdued profitability metrics limit internal funding for growth and reduce buffer against reimbursement cuts or wage inflation. Low ROE and narrow margins mean the business must maintain high utilization and tight cost control to generate acceptable returns, increasing operational leverage to adverse shocks.
0NQH FAQ
What was RHON-KLINIKUM AG’s price range in the past 12 months?
RHON-KLINIKUM AG lowest share price was €11.40 and its highest was €16.40 in the past 12 months.
What is RHON-KLINIKUM AG’s market cap?
RHON-KLINIKUM AG’s market cap is €836.73M.
When is RHON-KLINIKUM AG’s upcoming earnings report date?
RHON-KLINIKUM AG’s upcoming earnings report date is May 07, 2026 which is in 31 days.
How were RHON-KLINIKUM AG’s earnings last quarter?
RHON-KLINIKUM AG released its earnings results on Mar 26, 2026. The company reported €0.155 earnings per share for the quarter, beating the consensus estimate of N/A by €0.155.
Is RHON-KLINIKUM AG overvalued?
According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued.
Does RHON-KLINIKUM AG pay dividends?
RHON-KLINIKUM AG does not currently pay dividends.
What is RHON-KLINIKUM AG’s EPS estimate?
RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RHON-KLINIKUM AG have?
RHON-KLINIKUM AG has 66,962,470 shares outstanding.
What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?
RHON-KLINIKUM AG reported an EPS of €0.155 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of RHON-KLINIKUM AG?
Currently, no hedge funds are holding shares in GB:0NQH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
RHON-KLINIKUM AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.63%
12-Months-Change
Fundamentals
Return on Equity
2.93%
Trailing 12-Months
Asset Growth
1.20%
Trailing 12-Months
Company Description
RHON-KLINIKUM AG
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
Technical Analysis
Fresenius Medical Care AG & Co. KGaA
―
MEDICLIN
―
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
M1 Kliniken AG
―